| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $156.1M | — | -29.7% |
| Cost of Revenue | $72.0M | — | -18.6% |
| R&D Expense | $10.5M | — | -30.5% |
| SG&A Expense | $46.6M | — | -11.1% |
| Operating Income | $10.5M | — | -79.0% |
| Pre-tax Income | $13.4M | — | -85.5% |
| Income Tax | $6.6M | — | -73.3% |
| Net Income | $6.8M | — | -90.0% |
| EPS (Basic) | $0.13 | — | -89.6% |
| EPS (Diluted) | $0.07 | — | -94.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $160.3M | -22.0% | +7.5% |
| Accounts Receivable | $121.6M | +44.4% | -40.3% |
| Inventory | $327.6M | -4.6% | +4.3% |
| Current Assets | $637.6M | -3.8% | -9.8% |
| Total Assets | $1.32B | +0.1% | -7.4% |
| Current Liabilities | $148.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.8M | — | -201.8% |
| Capital Expenditures | $2.4M | — | -33.3% |
| Investing Cash Flow | -$2.4M | — | -104.0% |
| Financing Cash Flow | -$11.4M | — | -2750.0% |
| Free Cash Flow | -$36.2M | — | -144.6% |
| +32.9% |
| Long-term Debt | $589.7M | +0.0% | -15.8% |
| Total Liabilities | $797.3M | +0.2% | -8.7% |
| Stockholders' Equity | $523.1M | +0.1% | -5.4% |